| Over a quarter ago |
|
Recommendations
|
Barrington analyst… Barrington analyst Alexander Paris lowered the firm's price target on Universal Technical Institute to $10 from $14 and keeps an Outperform rating on the shares post the fiscal Q4 results. While fiscal 2023 will be a transition year as management integrates the Concorde acquisition, the company is setting up for a "strong performance" in fiscal 2024 and beyond, Paris tells investors in a research note. ShowHide Related Items >><< - 12/12/22
- Universal Technical falls -16.3%
- 12/12/22
- Universal Technical falls -10.6%
- 12/12/22
- Universal Technical trading resumes
- 12/12/22
- Universal Technical trading halted, volatility trading pause
- 12/13/22 Lake Street
- Universal Technical price target lowered to $10 from $12 at Lake Street
- 07/11/22 Rosenblatt
- Universal Technical initiated with a Buy at Rosenblatt
- 06/28/22 Argus
- Argus upgrades Universal Technical to Buy on expansion efforts, valuation
- 06/28/22 Argus
- Universal Technical upgraded to Buy from Hold at Argus
- 12/12/22
- Universal Technical reports Q4 EPS 3c vs 20c last year
- 11/21/22
- Universal Technical sees FY22 revenue $418.8M, consensus $418.98M
- 08/03/22
- Universal Technical narrows FY22 revenue view to $410M-$420M from $405.0M-$420M
- 08/03/22
- Universal Technical reports Q3 EPS (1c) vs. 3c a year ago
- 12/12/22
- What You Missed On Wall Street On Monday
- 12/12/22
- What You Missed On Wall Street This Morning
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
|
|
Recommendations
|
Lake Street analyst Eric… Lake Street analyst Eric Martinuzzi lowered the firm's price target on Universal Technical to $10 from $12 and keeps a Buy rating on the shares after the company reported Q4 results. He had been expecting Concorde - which the company completed its acquisition of on December 1 - to be additive to his prior, legacy Universal Technical AEBITDA forecast, but it now appears that "the incremental profits from Concorde are filling the profit weakness in the legacy UTI operations," Martinuzzi tells investors. ShowHide Related Items >><< - 12/12/22
- Universal Technical falls -16.3%
- 12/12/22
- Universal Technical falls -10.6%
- 12/12/22
- Universal Technical trading resumes
- 12/12/22
- Universal Technical trading halted, volatility trading pause
- 07/11/22 Rosenblatt
- Universal Technical initiated with a Buy at Rosenblatt
- 06/28/22 Argus
- Argus upgrades Universal Technical to Buy on expansion efforts, valuation
- 06/28/22 Argus
- Universal Technical upgraded to Buy from Hold at Argus
- 05/05/22 Barrington
- Universal Technical price target raised to $14 from $10 at Barrington
- 12/12/22
- Universal Technical reports Q4 EPS 3c vs 20c last year
- 11/21/22
- Universal Technical sees FY22 revenue $418.8M, consensus $418.98M
- 08/03/22
- Universal Technical narrows FY22 revenue view to $410M-$420M from $405.0M-$420M
- 08/03/22
- Universal Technical reports Q3 EPS (1c) vs. 3c a year ago
- 12/12/22
- What You Missed On Wall Street On Monday
- 12/12/22
- What You Missed On Wall Street This Morning
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 12/12/22
- Weber rises 23.3%
- 12/12/22
- Weber rises 23.3%
- 12/12/22
- Weber rises 23.1%
- 12/12/22
- Weber to be taken private by BDT Capital in $8.05 per share transaction
WBA Walgreens Boots Alliance - 12/08/22
- Walgreens Boots Alliance sells $1.0B in AmerisourceBergen shares
- 12/08/22
- Walgreens Boots Alliance launches free Paxlovid delivery with DoorDash, Uber
- 12/06/22
- Walmart to pay $500,000 over workers' compensation prescription procedures
- 11/08/22
- VMware, Equinix announce expanded global relationship
- 11/08/22
- HP Enterprise, VMware announce next phase of partnership
- 11/08/22
- Wipro, VMware extend collaboration with dedicated business unit
- 10/17/22
- VMware, First Nations University of Canada launch digital partnership
- 12/12/22
- Universal Technical falls -16.3%
- 12/12/22
- Universal Technical falls -10.6%
- 12/12/22
- Universal Technical trading resumes
- 12/12/22
- Universal Technical trading halted, volatility trading pause
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 10/05/22
- Under Armour announces executive leadership changes
- 08/03/22
- Under Armour sees 'overabundance' of product hitting the market in 2022
- 08/03/22
- Under Armour's Plank says Browne in running for permanent CEO job
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 09/09/22
- Tapestry announces long-term financial targets
- 08/04/22
- Tapestry COO Tom Glaser retires, Scott Roe to succeed
- 11/09/22
- Cinedigm reaches new distribution agreement with Samsung
- 11/03/22
- ironSource announces expansion of partnership with Samsung
- 10/31/22
- Rambus and Samsung extend comprehensive pact for additional 10 years
- 10/20/22
- Verizon starts orders for Samsung Galaxy XCover6 Pro
- 12/12/22
- Rivian Automotive pauses plans to produce electric commercial vans in Europe
- 12/06/22
- Vietnam-based EV maker VinFast plans for U.S. IPO
- 12/05/22
- Rivian Automotive enters wind energy deal with Apex Clean Energy
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- $253.52 /
-20.82 (-7.59%) - 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 12/08/22
- RH CEO to exercise expiring options
- 11/14/22
- Berkshire Hathaway adds TSMC, exits STORE Capital in Q3
- 11/02/22
- Qualcomm falls 7% to $104.90 after Q1 guidance misses estimates
- 11/02/22
- Qualcomm sees low-double digits handset volume declines for 2022
- 10/25/22
- Cognizant expands collaboration with Qualcomm
- 09/30/22
- L&T Technology Services, Qualcomm collaborate to deploy end-to-end 5G solutions
- 11/21/22
- Pitney Bowes confirms 'ongoing dialogue with Hestia Capital over many months'
- 11/21/22
- Activist Hestia wants Pitney Bowes to review capital and strategy, Reuters says
- 11/21/22
- Hestia Capital reports 6.9% stake in Pitney Bowes, engaging in talks
- 11/18/22
- Pitney Bowes announces 6.5% general rate increase for e-commerce services
- 11/18/22
- Pembina Pipeline announces settlement agreement with Ruby Pipeline
- 10/18/22
- TC Energy, Pembina Pipeline enter into carbon sequestration evaluation agreement
- 08/25/22
- Pembina Pipeline appoints Cameron Goldade as CFO
- 08/15/22
- Pembina Pipeline completes transaction with KKR to create PGI
- 12/06/22
- Micron ships Micron 2550 NVMe SSD to global PC OEM customers
- 11/29/22
- Micron CFO says pricing has trended 'well below' expectations
- 11/16/22
- Micron down 5% after warning outlook for 2023 has weakened
- 11/16/22
- Micron announces further actions to address market conditions
- 12/12/22
- Thomson Reuters, Blackstone to sell shares of LSEG to Microsoft
- 12/12/22
- Microsoft to buy 4% stake in LSEG amid 10-year cloud partnership
- 12/09/22
- Amazon, Bandai Namco partner over release of 'Blue Protocol' in 2023
- 11/08/22
- Levi Strauss appoints Michelle Gass as President, to succeed Bergh as CEO
- 10/07/22
- Levi Strauss falls -7.4%
- 10/06/22
- Levi Strauss falls 3% to $15.40 after Q3 earnings, FY22 guidance cut
- 07/28/22
- Kohl's becomes 'exclusive' wholesale retailer for Levi's SilverTab collection
- 12/12/22
- Karyopharm announces updated results from Phase 1 selinexor data
- 11/03/22
- Karyopharm to present new selinexor data in myelofibrosis and myeloma
- 11/01/22
- Karyopharm, Menarini Group: EC grants orphan designation for selinexor
- 10/31/22
- Karyopharm and Menarini announce EC granted orphan designation for selinexor
HZNP Horizon Therapeutics - $112.34 /
+14.995 (+15.40%) - 12/11/22
- Sanofi does not intend to make offer for Horizon Therapeutics
- 11/10/22
- GT Biopharma CEO says 'pleased with progress' with TriKE platform
- 09/12/22
- GT Biopharma announces highlights from GTB-5550 study
- 12/12/22
- Whole Earth Brands CEO Albert Manzone steps down
- 07/28/22
- Swerve launches next generation of sugar alternative products
- 06/21/22
- Whole Earth Brands announces global strategic ESG goals for 2030
- 06/17/22
- Whole Earth Brands increases revolving credit facility to $125M
- 12/12/22
- GT Biopharma, Fate present preclinical data on dual antigen targeting approach
- 12/11/22
- Fate presents interim data from dose-escalation stage of Phase 1 study of FT819
- 12/11/22
- Fate presents interim clinical data from ongoing Phase 1 stuty of FT576
- 11/07/22
- Fate announces exercise by ONO of option to FT825/ONO-8250
- 12/05/22
- Dynagas LNG reports new U.S. tax rules on PTPs don't affect unit holders
- 06/27/22
- Dynagas LNG reports Q1 EPS 18c vs. 21c in Q1 last year
- $103.78 /
+2.175 (+2.14%) - 12/12/22
- CVS, Walgreens in $10.7B opioid settlement with attorneys general
- 11/21/22
- CVS Health board approves 2022 Repurchase Program for $10B of shares
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 11/16/22
- Oak Street Health turns green, up 3% in afternoon trading
- 12/02/22
- Credit Suisse rallies after Chairman says outflows 'basically stopped'
- 11/23/22
- Credit Suisse sees likely loss for Wealth Management in Q4
- 11/23/22
- Credit Suisse sees 'substantial' loss of up to CHF 1.5B in Q4
- 11/23/22
- Credit Suisse confirms capital ratio guidance from October 27
- $78.62 /
+16.54 (+26.64%) - 12/12/22
- Coupa Software to be acquired by Thoma Bravo for $81 per share in cash
- 11/23/22
- Coupa Software up 34% after takeover report triggered halt
- 11/23/22
- Coupa Software trading resumes
- 11/23/22
- Coupa halted for volatility after jumping 10% on Bloomberg report
- 12/02/22
- Coinbase says Apple blocked last app release on NFTs
- 11/30/22
- Coinbase Wallet to stop supporting BCH, ETC, XLM, XRP
- 11/21/22
- Crypto names down in pre-market as bitcoin falls to one-week low
- 11/16/22
- Cathie Wood's ARK Investment bought 245.6K shares of Coinbase today
- 10/19/22
- Box renews partnership with Japan's Ministry of the Environment
- 08/24/22
- Box reports Q2 RPOs up 14% y/y at $1.05B
- 08/18/22
- Box announces appointment of Walia to board of directors
- 06/23/22
- Box announces collaboration with Fujifilm Business
- $276.76 /
-1.825 (-0.66%) - 12/12/22
- Amgen to acquire Horizon Therapeutics for $116.50 per share in cash
- 12/12/22
- Amgen to acquire Horizon Therapeutics for $116.50 per share in cash
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 12/07/22
- Cytokinetics initiates Phase 1 clinical study of CK-3828136
- $292.32 /
+4.085 (+1.42%) - 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 11/15/22
- Accenture to acquire Albert Inc., terms undisclosed
- 11/03/22
- Accenture names Andrew Levy chief corporate, government affairs officer
- 12/11/22
- Adicet Bio reports data from ongoing ADI-001 Phase 1 trial
- 11/29/22
- Adicet Bio appoints Nancy Boman, M.D Chief Regulatory Officer
- 10/17/22
- RA Capital Management reports 5.5% passive stake in Adicet Bio
- $276.76 /
-1.825 (-0.66%) - 12/13/22 BMO Capital
- Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
- 12/13/22 Baird
- Amgen deal yields nice accretion but large debt position, says Baird
- 12/13/22 Wells Fargo
- Horizon Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
- 12/13/22 Guggenheim
- Horizon Therapeutics downgraded to Neutral from Buy at Guggenheim
HZNP Horizon Therapeutics - $112.34 /
+14.995 (+15.40%) - $78.62 /
+16.54 (+26.64%) - 12/13/22 Needham
- Coupa Software downgraded to Hold from Buy at Needham
- 12/13/22 Wells Fargo
- Coupa Software price target raised to $81 from $65 at Wells Fargo
- 12/13/22 Needham
- Coupa Software downgraded to Hold from Buy at Needham
- 12/13/22 Wolfe Research
- Coupa Software downgraded to Peer Perform from Outperform at Wolfe Research
- 12/12/22 Credit Suisse
- Credit Suisse views Weber go-private deal 'positively'
- 10/25/22 Wells Fargo
- Weber upgraded to Equal Weight from Underweight at Wells Fargo
- 08/17/22 Citi
- Weber downgraded to Sell from Neutral at Citi
- 08/16/22 BMO Capital
- Weber price target lowered to $6 from $7 at BMO Capital
- 12/13/22 Canaccord
- Rivian Automotive production pause preserves capital, says Canaccord
- 12/13/22 Baird
- Rivian Automotive price target lowered to $44 from $51 at Baird
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line at Evercore ISI
- $103.78 /
+2.175 (+2.14%) - 11/23/22 Morgan Stanley
- CVS Health assumed with an Overweight at Morgan Stanley
- 11/21/22 Credit Suisse
- CVS Health price target raised to $125 from $117 at Credit Suisse
- 11/06/22 Raymond James
- CVS Health price target lowered to $115 from $120 at Raymond James
- 11/02/22 B. Riley
- B. Riley downgrades Semler Scientific on risk from Signify buyout
WBA Walgreens Boots Alliance - 11/23/22 Morgan Stanley
- Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
- 11/22/22 TD Cowen
- Walgreens upgraded to Outperform on services transition at Cowen
- 11/22/22 TD Cowen
- Walgreens Boots Alliance upgraded to Outperform from Market Perform at Cowen
- 11/18/22 JPMorgan
- Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
- 12/12/22 Deutsche Bank
- Micron downgraded to Hold from Buy at Deutsche Bank
- 12/07/22 Wells Fargo
- Micron price target lowered to $70 from $75 at Wells Fargo
- 12/05/22 Lynx
- Micron price target raised to $60 from $56 at Lynx
- 11/30/22 Stifel
- Micron management's tone 'incrementally downbeat,' says Stifel
- 12/12/22 Stifel
- Under Armour upgraded to Buy from Hold at Stifel
- 11/07/22 JPMorgan
- Under Armour price target raised to $11 from $10 at JPMorgan
- 11/01/22 BofA
- Under Armour reinstated with a Neutral at BofA
- 10/31/22 JPMorgan
- Under Armour price target lowered to $10 from $12 at JPMorgan
- 12/12/22 Wells Fargo
- Wells Fargo downgrades Qualcomm to Underweight with $105 price target
- 12/12/22 Wells Fargo
- Qualcomm downgraded to Underweight from Equal Weight at Wells Fargo
- 11/15/22 Credit Suisse
- Qualcomm initiated with an Outperform at Credit Suisse
- 11/03/22 KeyBanc
- Qualcomm price target lowered to $150 from $170 at KeyBanc
- $292.32 /
+4.085 (+1.42%) - 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 09/27/22 Alliance Global Partners
- Perficient upgraded to Buy from Neutral at Alliance Global Partners
- 12/13/22 Morgan Stanley
- Nike price target raised to $127 from $120 at Morgan Stanley
- 12/12/22 Goldman Sachs
- Tapestry upgraded to Buy from Neutral at Goldman Sachs
- 11/29/22 JPMorgan
- Tapestry price target raised to $47 from $46 at JPMorgan
- 11/14/22 Citi
- Tapestry price target lowered to $40 from $42 at Citi
- $253.52 /
-20.82 (-7.59%) - 12/13/22 Needham
- Williams-Sonoma initiated with a Hold at Needham
- 12/12/22 TD Cowen
- RH price target lowered to $320 from $350 at Cowen
- 12/12/22 Loop Capital
- RH price target lowered to $370 from $420 at Loop Capital
- 12/12/22 Barclays
- RH price target raised to $254 from $243 at Barclays
- 12/12/22 Goldman Sachs
- Levi Strauss downgraded to Neutral from Buy at Goldman Sachs
- 11/29/22 JPMorgan
- Levi Strauss price target lowered to $19 from $20 at JPMorgan
- 10/10/22 Citi
- Levi Strauss price target lowered to $19 from $27 at Citi
- 10/07/22 Guggenheim
- Levi Strauss price target lowered to $27 from $33 at Guggenheim
- 12/12/22 KeyBanc
- Coinbase initiated with a Sector Weight at KeyBanc
- 12/12/22 Mizuho
- Fiserv price target lowered to $135 from $145 at Mizuho
- 12/09/22 Mizuho
- Coinbase downgraded to Underperform from Neutral at Mizuho
- 12/05/22 Atlantic Equities
- Coinbase price target lowered to $46 from $67 at Atlantic Equities
- 11/25/22 William Blair
- Report about Galaxy S23 'significant positive' for Iridium, says William Blair
- 08/22/22 Loop Capital
- Enovix price target raised to $100 from $50 at Loop Capital
- 08/11/22 Loop Capital
- Loop Capital has 'stronger conviction' in Enovix after 'customer milestones'
- 06/22/22 Loop Capital
- Samsung initiated with a Buy at Loop Capital
- 12/09/22 BofA
- BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential
- 12/09/22 BofA
- Credit Suisse upgraded to Buy from Neutral at BofA
- 12/01/22 JPMorgan
- Credit Suisse price target lowered to CHF 3.80 from CHF 5.50 at JPMorgan
- 11/07/22 AlphaValue/Baader
- Credit Suisse downgraded to Sell from Buy at AlphaValue/Baader
- 12/08/22 Citi
- DoD contracts shows competitiveness of cloud industry, says Citi
- 12/07/22 BTIG
- SentinelOne price target lowered to $20 from $25 at BTIG
- 12/01/22 BMO Capital
- Okta price target raised to $69 from $58 at BMO Capital
- 12/01/22 Wedbush
- Activision Blizzard added to Best Ideas List at Wedbush
- 11/15/22 Mizuho
- VMware price target lowered to $135 from $138 at Mizuho
- 10/17/22 Needham
- Nutanix price target raised to $31 from $25 at Needham
- 10/17/22 Northland
- Salesforce initiated with a Market Perform at Northland
- 07/06/22 Raymond James
- VMware downgraded to Market Perform from Outperform at Raymond James
- 02/02/22 Maxim
- Pitney Bowes price target lowered to $7 from $12 at Maxim
- 12/12/22 RBC Capital
- Coupa Software upgraded to Sector Perform from Underperform at RBC Capital
- 12/12/22 JPMorgan
- JPMorgan upgrades 'undervalued profitable growth story' Box to buy
- 12/12/22 JPMorgan
- Box upgraded to Overweight from Neutral at JPMorgan
- 11/21/22 Credit Suisse
- Box initiated with an Outperform at Credit Suisse
- 12/12/22 H.C. Wainwright
- Adicet Bio price target raised to $38 from $34 at H.C. Wainwright
- 09/21/22 JPMorgan
- Adicet Bio initiated with Overweight, $23 target at JPMorgan
- 09/21/22 JPMorgan
- Adicet Bio initiated with an Overweight at JPMorgan
- 03/30/22 SMBC Nikko
- Adicet Bio initiated with an Outperform at SMBC Nikko
- 11/04/22 RBC Capital
- Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
- 11/04/22 RBC Capital
- Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
- 08/05/22 Baird
- Karyopharm price target lowered to $14 from $17 at Baird
- 08/05/22 Barclays
- Karyopharm price target lowered to $8 from $14 at Barclays
- 12/12/22 Oppenheimer
- Fate Therapeutics price target lowered to $65 from $90 at Oppenheimer
- 11/16/22 Citi
- Fate Therapeutics price target lowered to $80 from $87 at Citi
- 11/04/22 Cantor Fitzgerald
- Fate Therapeutics assumed with an Overweight at Cantor Fitzgerald
- 10/10/22 Canaccord
- Fate Therapeutics initiated with a Buy at Canaccord
- 09/13/22 H.C. Wainwright
- GT Biopharma price target lowered to $5 from $25 at H.C. Wainwright
- 08/11/22 Roth MKM
- Roth cuts GT Biopharma to Neutral after filings for TriKE programs pushed back
- 08/11/22 Roth MKM
- GT Biopharma downgraded to Neutral from Buy at Roth Capital
- 01/24/22 B. Riley
- GT Biopharma price target lowered to $18 from $26 at B. Riley
- 11/21/22 TD Cowen
- Whole Earth Brands price target lowered to $11 from $14 at Cowen
- 11/10/22 Canaccord
- Whole Earth Brands price target lowered to $8 from $10 at Canaccord
- 03/15/22 Lake Street
- Whole Earth Brands price target lowered to $16 from $19 at Lake Street
- 03/15/22 Cantor Fitzgerald
- Whole Earth Brands price target lowered to $19.00 from $24.75 at Cantor Fitzgerald
- 07/11/22 Rosenblatt
- Universal Technical initiated with a Buy at Rosenblatt
- 06/28/22 Argus
- Argus upgrades Universal Technical to Buy on expansion efforts, valuation
- 06/28/22 Argus
- Universal Technical upgraded to Buy from Hold at Argus
- 05/05/22 Barrington
- Universal Technical price target raised to $14 from $10 at Barrington
- 04/27/22 Jefferies
- Dynagas LNG reinstated with a Hold at Jefferies
- 12/09/22 Credit Suisse
- Pembina Pipeline downgraded to Neutral from Outperform at Credit Suisse
- 11/07/22 National Bank
- Pembina Pipeline price target raised to C$46 from C$45 at National Bank
- 11/04/22 Raymond James
- Pembina Pipeline price target lowered to C$46 from C$49 at Raymond James
- 10/20/22 Scotiabank
- Pembina Pipeline price target lowered to C$50 from C$55 at Scotiabank
- 08/15/22
- Weber reports Q3 EPS (41c)
- 07/25/22
- Weber withdraws FY22 guidance, suspends dividend
- 07/25/22
- Weber sees Q3 revenue $525M-$530M, consensus $532.74M
WBA Walgreens Boots Alliance - 10/13/22
- Walgreens Boots Alliance sees FY23 adjusted EPS $4.45-$4.65, consensus $5.01
- 10/13/22
- Walgreens Boots Alliance reports Q4 adjusted EPS 80c, consensus 77c
- 10/12/22
- Notable companies reporting before tomorrow's open
- 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 11/22/22
- VMware reports Q3 adjusted EPS $1.47, consensus $1.58
- 08/25/22
- VMware reports Q2 adjusted EPS $1.64 vs $1.75 last year
- 08/25/22
- Notable companies reporting after market close
- 12/12/22
- Virco reports Q3 EPS 48c vs. 8c last year
- 12/12/22
- Universal Technical reports Q4 EPS 3c vs 20c last year
- 11/21/22
- Universal Technical sees FY22 revenue $418.8M, consensus $418.98M
- 08/03/22
- Universal Technical narrows FY22 revenue view to $410M-$420M from $405.0M-$420M
- 08/03/22
- Universal Technical reports Q3 EPS (1c) vs. 3c a year ago
- 11/03/22
- Under Armour cuts FY23 EPS view to 56c-60c from 61c-67c, consensus 43c
- 11/03/22
- Under Armour reports Q2 adjusted EPS 20c, consensus 16c
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/10/22
- Tapestry sees FY23 EPS $3.60-$3.70, consensus $3.82
- 11/10/22
- Tapestry reports Q1 EPS 79c, consensus 75c
- 11/09/22
- Notable companies reporting before tomorrow's open
- 10/26/22
- Samsung reports Q3 net profit KRW 9.39T vs. KRW 12.29T last year
- 10/06/22
- Samsung sees Q3 operating profit KRW10.8T vs. KRW12.1T consensus
- 07/28/22
- Samsung reports Q2 EPS KRW 1,613 vs. KRW 1,391 last year
- 07/06/22
- Samsung sees Q2 operating profit KRW14.0T vs. KRW14.6T consensus
- 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
- 11/09/22
- Notable companies reporting after market close
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 08/11/22
- Rivian Automotive reports Q2 EPS ($1.89), consensus ($1.67)
- $253.52 /
-20.82 (-7.59%) - 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 11/02/22
- Qualcomm sees Q1 adjusted EPS adjusted EPS $2.25-$2.45, consensus $3.42
- 11/02/22
- Qualcomm reports Q4 adjusted EPS $3.13, consensus $3.13
- 11/02/22
- Notable companies reporting after market close
- 07/27/22
- Qualcomm sees Q4 adjusted EPS $3.00-$3.30, consensus $3.23
- 11/01/22
- PBI backs FY22 revenue view down low-single digits to up low single digits
- 11/01/22
- Pitney Bowes reports Q3 adjusted EPS 0c, consensus 2c
- 12/12/22
- Pembina Pipeline sees FY23 adjusted EBITDA C$3.5B-C$3.8B
- 11/03/22
- Pembina Pipeline reports Q3 EPS C$3.23 vs. C$1.01 a year ago
- 08/04/22
- Pembina Pipeline raises FY22 adjusted EBITDA view to C$3.575B-C$3.675B
- 08/04/22
- Pembina Pipeline reports Q2 EPS C$0.69 vs. C$0.39 a year ago
- 09/29/22
- Micron sees Q2 revenue range similar to Q1
- 09/29/22
- Micron sees Q1 adjusted EPS 4c, plus or minus 10c, consensus 64
- 09/29/22
- Micron reports Q4 adjusted EPS $1.45, consensus $1.30
- 09/29/22
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 10/25/22
- Notable companies reporting after market close
- 07/26/22
- Microsoft sees FY23 revenue growth in double digits, consensus $225.98B
- 10/06/22
- Levi Strauss cuts FY22 EPS view to $1.44-$1.49 from $1.50-$1.56
- 10/06/22
- Levi Strauss reports Q3 EPS 40c, consensus 37c
- 07/07/22
- Levi Strauss backs FY22 adjusted EPS view $1.50-$1.56, consensus $1.55
- 07/07/22
- Levi Strauss reports Q2 adjusted EPS 29c, consensus 23c
- 11/03/22
- Karyopharm sees FY22 revenue $155M-$165M, consensus $157.23M
- 11/03/22
- Karyopharm reports Q3 EPS (45) with items, consensus (57c)
- 08/04/22
- Karyopharm sees 2022 revenue $155M-$165M, consensus $160.03M
- 08/04/22
- Karyopharm reports Q2 EPS (62c), consensus (63c)
HZNP Horizon Therapeutics - $112.34 /
+14.995 (+15.40%) - 11/02/22
- Horizon Therapeutics sees FY22 revenue s $3.59B-$3.61B, consensus $3.56B
- 11/02/22
- Horizon Therapeutics reports Q3 EPS $1.25, consensus $1.01
- 08/03/22
- Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B
- 08/03/22
- Horizon Therapeutics reports Q2 adjusted EPS $1.07, consensus $1.35
- 12/12/22
- Whole Earth Brands reaffirms 2022 guidance
- 11/09/22
- Whole Earth Brands sees 2022 revenue $535M-$545M, consensus $535.57M
- 11/09/22
- Whole Earth Brands reports Q3 EPS (6c), consensus 8c
- 08/09/22
- Whole Earth Brands reiterates FY22 revenue view $530M-$545M, consensus $536.83M
- 11/03/22
- Fate Therapeutics reports Q3 EPS (86c), consensus (89c)
- 08/03/22
- Fate Therapeutics reports Q2 EPS (79c), consensus (83c)
- 12/12/22
- Dynagas LNG reports Q3 adjusted EPS 4c vs. 24c last year
- 09/22/22
- Dynagas LNG reports Q2 EPS 17c vs. 20c in last year's quarter
- $103.78 /
+2.175 (+2.14%) - 11/02/22
- CVS Health sees FY23 adjusted EPS $8.70-$8.90, consensus $9.06
- 11/02/22
- CVS Health raises FY22 revenue view to $309B-$314B from $307B-$312B
- 11/02/22
- CVS Health raises FY22 adjusted EPS view to $8.55-$8.65 from $8.40-$8.60
- 11/02/22
- CVS Health reports Q3 adjusted EPS $2.09, consensus $1.99
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 07/27/22
- Credit Suisse reports Q2 net revenue CHF3.6B vs. CHF5.1B last year
- $78.62 /
+16.54 (+26.64%) - 12/12/22
- Coupa Software reports Q3 non-GAAP EPS 15c, consensus 10c
- 09/06/22
- Coupa Software sees FY23 non-GAAP EPS 37c-44c, consensus 26c
- 09/06/22
- Coupa Software sees Q3 non-GAAP EPS 8c-10c, consensus 6c
- 09/06/22
- Coupa Software reports Q2 non-GAAP EPS 20c, consensus 9c
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 11/03/22
- Coinbase reports Q3 EPS ($2.43), consensus ($2.40)
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 11/30/22
- Box raises FY23 EPS view to $1.16-$1.17 from $1.13-$1.16, consensus $1.14
- 11/30/22
- Box sees Q4 adjusted EPS 34c-35c, consensus 33c
- 11/30/22
- Box reports Q3 adjusted EPS 31c, consensus 30c
- 11/30/22
- Notable companies reporting after market close
- $276.76 /
-1.825 (-0.66%) - 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
- $292.32 /
+4.085 (+1.42%) - 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 09/22/22
- Accenture sees FY23 EPS $11.09-$11.41, consensus $12.00
- 09/22/22
- Accenture reports Q4 EPS $2.60, consensus $2.58
- 06/23/22
- Accenture sees Q4 revenue $15B-$15.5B, consensus $14.83B
- 11/08/22
- Adicet Bio reports Q3 EPS (53c), consensus (53c)
- 08/10/22
- Adicet Bio reports Q2 EPS (56c), consensus (45c)
- 10/11/22
- Weber considering debt financing from shareholder BDT, Bloomberg reports
- 10/11/22
- Weber received private equity takeover approach, Street Insider says
- 06/23/22
- Weber, Traeger rallies punish short sellers, Bloomberg says
WBA Walgreens Boots Alliance - 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- 11/01/22
- Walgreens, Walmart, CVS reach $12B opioid settlement deal, Bloomberg reports
- 11/01/22
- Walgreens-backed VillageMD in talks to merge with Summit, Bloomberg reports
- 10/02/22
- Walgreens turns to prescription-filling robots to free up pharmacists, WSJ says
- 12/12/22
- Three top executives to leave VMware, WSJ reports
- 12/09/22
- Broadcom facing antitrust investigation by EU into VMware deal, Reuters says
- 12/09/22
- Broadcom facing antitrust investigation by EU into VMware deal, Reuters reports
- 10/16/22
- Broadcom banks on early EU approval of $61B VMware deal, Reuters says
- 09/14/22
- Steph Curry said to be near $1B lifetime deal with Under Armour, Tribune reports
- 07/29/22
- Under Armour pays $67.5M to settle UCLA lawsuit, LA Times says
- 12/03/22
- Tapestry, Saia among small-cap stocks set for big gains, Barron's says
- 10/13/22
- Samsung granted one-year exemption from new U.S. chip restrictions, WSJ reports
- 11/12/22
- EV stocks face a reckoning, not all will survive, Barron's says
- 11/07/22
- Amazon has 'hundreds' of Rivian vans making deliveries, The Verge reports
- 10/19/22
- Rivian has fixed 'majority' of recalled vehicles, TechCrunch reports
- 08/19/22
- Rivian drops cheapest version of electric pickup truck, Bloomberg reports
- 12/08/22
- Qualcomm ends major program, SemiAccurate reports
- 11/17/22
- TSMC to make latest Qualcomm flagship smartphone chips, DigiTimes reports
- 11/02/22
- Qualcomm implements hiring freeze, CNBC reports
- 12/12/22
- Samsung to maintain memory output ramp-up, DigiTimes reports
- 11/29/22
- Micron to ramp up 1-beta DRAM shipments by end of year, DigiTimes reports
- 10/06/22
- Restrictions on China chipmakers won't target SK Hynix and Samsung, Reuters says
- 10/06/22
- U.S. to effectively halt some NAND, DRAM equipment export to China, Reuters says
- 12/12/22
- Microsoft made concession offer to EU over antitrust concerns, Reuters says
- 12/12/22
- Microsoft seeks to settle EU concerns about business practices, Reuters reports
- 12/11/22
- FTC tussle with Microsoft puts spotlight on cloud gaming, WSJ says
- 12/10/22
- Microsoft, Arista among stocks that can survive a triple whammy, Barron's says
HZNP Horizon Therapeutics - $112.34 /
+14.995 (+15.40%) - 12/04/22
- J&J says won't make offer for Horizon Therapeutics, Bloomberg reports
- 11/04/22
- Barclays' boosted stake in Horizon Therapeutics 'interesting,' DealReporter says
- 10/14/22
- U.K. in talks with U.S. LNG producers over purchase agreements, Sky News says
- $103.78 /
+2.175 (+2.14%) - 12/10/22
- CVS big bet on primary care hasn't yet come to pass, Barron's says
- 12/04/22
- CVS testing remote system to help fill prescriptions, WSJ reports
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 11/20/22
- JPMorgan taps Walmart exec for new health venture, Bloomberg says
- 12/12/22
- Credit Suisse accepted 'suspicious' invoices for Greensill loan, FT reports
- 12/05/22
- Credit Suisse chairman says outflows have 'stabilised,' Reuters reports
- 12/04/22
- Credit Suisse's investment bank spinoff attracts Saudi Crown Prince, WSJ says
- 12/01/22
- Credit Suisse eyes ways to accelerate cost cuts, Reuters reports
- $78.62 /
+16.54 (+26.64%) - 11/23/22
- Vista Equity Partners exploring deal to buy Coupa Software, Bloomberg says
- 11/23/22
- Vista Equity exploring deal to buy Coupa Software, Bloomberg says
- 11/23/22
- Vista Equity exploring acquisition of Coupa Software, Bloomberg says
- 12/12/22
- Coinbase CEO Armstrong believes regulation will boost USD Coin use, WSJ reports
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 11/19/22
- Crypto's survival may now depend on Washington, Barron's says
- 11/13/22
- At least $1B of client funds missing at FTX, Reuters reports
- $276.76 /
-1.825 (-0.66%) - 12/11/22
- Amgen nears deal to acquire Horizon Therapeutics, WSJ reports
- 11/04/22
- Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says
- 08/01/22
- Amgen battles IRS over $10.7B in back taxes, WSJ reports
- $292.32 /
+4.085 (+1.42%) - 12/05/22
- Allstate replacing Accenture's Droga5 for creative account, AdAge reports
- 11/04/22
- Short Report: Bears keen to further pile on credit lending names
WBA Walgreens Boots Alliance - 11/26/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 11/22/22
- What You Missed On Wall Street On Tuesday
- 11/22/22
- What You Missed On Wall Street This Morning
- 11/23/22
- What You Missed On Wall Street On Wednesday
- 11/23/22
- What You Missed On Wall Street This Morning
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
- 08/18/22
- What You Missed On Wall Street On Thursday
- 10/04/22
- What You Missed On Wall Street On Tuesday
- 09/21/22
- What You Missed On Wall Street On Wednesday
- 12/12/22
- What You Missed This Week in EVs and Clean Energy
- $253.52 /
-20.82 (-7.59%) - 12/09/22
- What You Missed On Wall Street On Friday
- 12/09/22
- What You Missed On Wall Street This Morning
- 12/12/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/09/22
- Fly Intel: Pre-market Movers
- 12/08/22
- What You Missed On Wall Street On Thursday
- 11/08/22
- What You Missed On Wall Street On Tuesday
- 11/08/22
- What You Missed On Wall Street This Morning
HZNP Horizon Therapeutics - $112.34 /
+14.995 (+15.40%) - 12/12/22
- Fly Intel: Pre-market Movers
- 12/05/22
- What You Missed On Wall Street On Monday
- 11/04/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/23/22
- Fly Intel: Pre-market Movers
- 09/22/22
- Fly Intel: After-Hours Movers
- $103.78 /
+2.175 (+2.14%) - 12/05/22
- What You Missed On Wall Street This Morning
- 11/23/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/09/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $78.62 /
+16.54 (+26.64%) - 11/25/22
- What You Missed On Wall Street On Friday
- 12/12/22
- Fly Insider: comScore, Donegal Group among week's notable insider trades
- 10/03/22
- What You Missed On Wall Street On Monday
- 10/03/22
- What You Missed On Wall Street This Morning
- $276.76 /
-1.825 (-0.66%) - 12/12/22
- What You Missed On Wall Street On Monday
- 12/12/22
- What You Missed On Wall Street This Morning
- 11/30/22
- What You Missed On Wall Street On Wednesday
- 11/30/22
- What You Missed On Wall Street This Morning
- $292.32 /
+4.085 (+1.42%) - 09/22/22
- What You Missed On Wall Street On Thursday
- 11/23/22
- Largest borrow rate increases among liquid names
- 11/02/22
- Largest borrow rate increases among liquid names
- 11/01/22
- Largest borrow rate increases among liquid names
- 10/31/22
- Largest borrow rate increases among liquid names
WBA Walgreens Boots Alliance - 11/11/22
- Unusually active option classes on open November 11th
- 11/07/22
- Early notable gainers among liquid option names on November 7th
- 11/07/22
- Unusually active option classes on open November 7th
- 10/13/22
- Early notable gainers among liquid option names on October 13th
- 08/25/22
- VMware options imply 1.2% move in share price post-earnings
- 10/31/22
- Under Armour Class A call volume above normal and directionally bullish
- 10/10/22
- Under Armour Class A call volume above normal and directionally bullish
- 08/03/22
- Unusually active option classes on open August 3rd
- 06/30/22
- Under Armour Class A put volume heavy and directionally bearish
- 11/04/22
- Unusually active option classes on open November 4th
- 09/12/22
- Early notable gainers among liquid option names on September 12th
- 09/01/22
- Tapestry call volume above normal and directionally bullish
- 11/09/22
- Rivian options imply 10.8% move in share price post-earnings
- 10/10/22
- Unusually active option classes on open October 10th
- 10/06/22
- Unusually active option classes on open October 6th
- 09/29/22
- Unusually active option classes on open September 29th
- $253.52 /
-20.82 (-7.59%) - 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
- 09/06/22
- Restoration Hardware call volume above normal and directionally bullish
- 08/31/22
- Qualcomm sued by Arm for contract breach, infringement, Bloomberg says
- 07/27/22
- Qualcomm options imply 6.3% move in share price post-earnings
- 06/27/22
- Qualcomm call volume above normal and directionally bullish
- 06/13/22
- Qualcomm call volume above normal and directionally bullish
- 09/29/22
- Micron options imply 5.2% move in share price post-earnings
- 09/01/22
- Micron put volume heavy and directionally bearish
- 08/15/22
- Micron call volume above normal and directionally bullish
- 08/09/22
- Unusually active option classes on open August 9th
- 12/12/22
- Early notable gainers among liquid option names on December 12th
- 11/10/22
- Microsoft put buyer realizes 13% same-day gains
- 10/25/22
- Microsoft options imply 3.9% move in share price post-earnings
- 09/16/22
- Microsoft put buyer realizes 22% same-day gains
- 10/19/22
- Levi Strauss call volume above normal and directionally bullish
- 10/06/22
- Levi Strauss options imply 7.1% move in share price post-earnings
- 07/07/22
- Levi Strauss options imply 6.6% move in share price post-earnings
HZNP Horizon Therapeutics - $112.34 /
+14.995 (+15.40%) - 12/12/22
- Unusually active option classes on open December 12th
- 12/02/22
- Horizon Pharma put volume heavy and directionally bearish
- 11/30/22
- Unusually active option classes on open November 30th
- $103.78 /
+2.175 (+2.14%) - 11/28/22
- CVS Health put volume heavy and directionally bearish
- 11/02/22
- Unusually active option classes on open November 2nd
- 10/19/22
- Unusually active option classes on open October 19th
- 09/13/22
- CVS Health call volume above normal and directionally bullish
- 12/12/22
- Notable open interest changes for December 12th
- 12/02/22
- Unusually active option classes on open December 2nd
- $78.62 /
+16.54 (+26.64%) - 11/07/22
- Coupa Software put volume heavy and directionally bearish
- 11/04/22
- Coupa Software put volume heavy and directionally bearish
- 11/03/22
- Coupa Software put volume heavy and directionally bearish
- 11/01/22
- Coupa Software call volume above normal and directionally bullish
- 11/18/22
- Coinbase put volume heavy and directionally bearish
- 11/09/22
- Unusually active option classes on open November 9th
- 11/09/22
- Notable open interest changes for November 9th
- 11/08/22
- Coinbase put buyer realizes 72% same-day gains
- 11/30/22
- Box options imply 5.4% move in share price post-earnings
- 08/24/22
- Box options imply 4.5% move in share price post-earnings
- $276.76 /
-1.825 (-0.66%) - 10/11/22
- Early notable gainers among liquid option names on October 11th
- 07/12/22
- Amgen put volume heavy and directionally bearish
- 06/27/22
- Amgen put volume heavy and directionally bearish
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 12/12/22
- Weber rises 23.3%
- 12/12/22
- Weber rises 23.3%
- 12/12/22
- Weber rises 23.1%
- 12/12/22
- Weber to be taken private by BDT Capital in $8.05 per share transaction
- 12/12/22
- Meridian Bioscience announces anticipated closing date of pending merger
- 11/22/22
- Meridian Bioscience expects to complete merger with SDB, SJL by end of 2022
- 10/11/22
- Meridian says CFIUS application accepted for review, working with DoJ on probe
- 07/29/22
- Meridian receives re-authorization of its EUA for Revogene assay from FDA
- 12/12/22
- Universal Technical falls -16.3%
- 12/12/22
- Universal Technical falls -10.6%
- 12/12/22
- Universal Technical trading resumes
- 12/12/22
- Universal Technical trading halted, volatility trading pause
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 10/05/22
- Under Armour announces executive leadership changes
- 08/03/22
- Under Armour sees 'overabundance' of product hitting the market in 2022
- 08/03/22
- Under Armour's Plank says Browne in running for permanent CEO job
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 09/09/22
- Tapestry announces long-term financial targets
- 08/04/22
- Tapestry COO Tom Glaser retires, Scott Roe to succeed
- 11/09/22
- Cinedigm reaches new distribution agreement with Samsung
- 11/03/22
- ironSource announces expansion of partnership with Samsung
- 10/31/22
- Rambus and Samsung extend comprehensive pact for additional 10 years
- 10/20/22
- Verizon starts orders for Samsung Galaxy XCover6 Pro
- 12/12/22
- Rivian Automotive pauses plans to produce electric commercial vans in Europe
- 12/06/22
- Vietnam-based EV maker VinFast plans for U.S. IPO
- 12/05/22
- Rivian Automotive enters wind energy deal with Apex Clean Energy
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- $252.26 /
-22.08 (-8.05%) - 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 12/08/22
- RH CEO to exercise expiring options
- 11/14/22
- Berkshire Hathaway adds TSMC, exits STORE Capital in Q3
- 11/02/22
- Qualcomm falls 7% to $104.90 after Q1 guidance misses estimates
- 11/02/22
- Qualcomm sees low-double digits handset volume declines for 2022
- 10/25/22
- Cognizant expands collaboration with Qualcomm
- 09/30/22
- L&T Technology Services, Qualcomm collaborate to deploy end-to-end 5G solutions
- 11/18/22
- Pembina Pipeline announces settlement agreement with Ruby Pipeline
- 10/18/22
- TC Energy, Pembina Pipeline enter into carbon sequestration evaluation agreement
- 08/25/22
- Pembina Pipeline appoints Cameron Goldade as CFO
- 08/15/22
- Pembina Pipeline completes transaction with KKR to create PGI
- 12/12/22
- Inotiv: Q1 earnings, liquidity could be impacted by Cambodian NHPs
- 12/08/22
- Inotiv announces new site openings, capacity expansion
- 11/29/22
- Inotiv announces facilities consolidations plans
- 11/18/22
- Inotiv trading resumes
- 12/06/22
- Micron ships Micron 2550 NVMe SSD to global PC OEM customers
- 11/29/22
- Micron CFO says pricing has trended 'well below' expectations
- 11/16/22
- Micron down 5% after warning outlook for 2023 has weakened
- 11/16/22
- Micron announces further actions to address market conditions
- 12/12/22
- Thomson Reuters, Blackstone to sell shares of LSEG to Microsoft
- 12/12/22
- Microsoft to buy 4% stake in LSEG amid 10-year cloud partnership
- 12/09/22
- Amazon, Bandai Namco partner over release of 'Blue Protocol' in 2023
- 11/08/22
- Levi Strauss appoints Michelle Gass as President, to succeed Bergh as CEO
- 10/07/22
- Levi Strauss falls -7.4%
- 10/06/22
- Levi Strauss falls 3% to $15.40 after Q3 earnings, FY22 guidance cut
- 07/28/22
- Kohl's becomes 'exclusive' wholesale retailer for Levi's SilverTab collection
- 12/12/22
- Karyopharm announces updated results from Phase 1 selinexor data
- 11/03/22
- Karyopharm to present new selinexor data in myelofibrosis and myeloma
- 11/01/22
- Karyopharm, Menarini Group: EC grants orphan designation for selinexor
- 10/31/22
- Karyopharm and Menarini announce EC granted orphan designation for selinexor
- 12/08/22
- IAC reports November Angi Inc. total revenue up 5% from last year
- 11/08/22
- IAC CEO says 'will fix mistakes' at both IAC and Angi
- 11/07/22
- Barry Diller tells CNBC he hopes Netflix stays independent
HZNP Horizon Therapeutics - $112.03 /
+14.68 (+15.08%) - 12/11/22
- Sanofi does not intend to make offer for Horizon Therapeutics
- 11/10/22
- GT Biopharma CEO says 'pleased with progress' with TriKE platform
- 09/12/22
- GT Biopharma announces highlights from GTB-5550 study
- 11/17/22
- Gap rises 8% to nearly $14 after Q3 results
- 11/10/22
- Gap launches collection of 'family essentials' with Amazon Fashion
- 10/25/22
- Gap 'taking immediate steps' to remove Yeezy Gap product from stores
- 09/28/22
- Gap unit Athleta teams with thredUP, and Shop Premium Outlets for online
- 12/12/22
- Whole Earth Brands CEO Albert Manzone steps down
- 07/28/22
- Swerve launches next generation of sugar alternative products
- 06/21/22
- Whole Earth Brands announces global strategic ESG goals for 2030
- 06/17/22
- Whole Earth Brands increases revolving credit facility to $125M
- 12/12/22
- GT Biopharma, Fate present preclinical data on dual antigen targeting approach
- 12/11/22
- Fate presents interim data from dose-escalation stage of Phase 1 study of FT819
- 12/11/22
- Fate presents interim clinical data from ongoing Phase 1 stuty of FT576
- 11/07/22
- Fate announces exercise by ONO of option to FT825/ONO-8250
- 12/05/22
- Dynagas LNG reports new U.S. tax rules on PTPs don't affect unit holders
- 06/27/22
- Dynagas LNG reports Q1 EPS 18c vs. 21c in Q1 last year
- 12/02/22
- Credit Suisse rallies after Chairman says outflows 'basically stopped'
- 11/23/22
- Credit Suisse sees likely loss for Wealth Management in Q4
- 11/23/22
- Credit Suisse sees 'substantial' loss of up to CHF 1.5B in Q4
- 11/23/22
- Credit Suisse confirms capital ratio guidance from October 27
- $78.70 /
+16.62 (+26.77%) - 12/12/22
- Coupa Software to be acquired by Thoma Bravo for $81 per share in cash
- 11/23/22
- Coupa Software up 34% after takeover report triggered halt
- 11/23/22
- Coupa Software trading resumes
- 11/23/22
- Coupa halted for volatility after jumping 10% on Bloomberg report
- 12/02/22
- Coinbase says Apple blocked last app release on NFTs
- 11/30/22
- Coinbase Wallet to stop supporting BCH, ETC, XLM, XRP
- 11/21/22
- Crypto names down in pre-market as bitcoin falls to one-week low
- 11/16/22
- Cathie Wood's ARK Investment bought 245.6K shares of Coinbase today
- 10/19/22
- Box renews partnership with Japan's Ministry of the Environment
- 08/24/22
- Box reports Q2 RPOs up 14% y/y at $1.05B
- 08/18/22
- Box announces appointment of Walia to board of directors
- 06/23/22
- Box announces collaboration with Fujifilm Business
- 12/08/22
- Activision Blizzard CEO confident Microsoft deal will close
- 12/08/22
- Microsoft's Smith has 'complete confidence' in case regarding Activision deal
- 12/08/22
- FTC announces suit seeking to block Microsoft from buying Activision
- 12/08/22
- Activision falls 2% to $74.05 after Bloomberg report of FTC suit
- $275.13 /
-3.455 (-1.24%) - 12/12/22
- Amgen to acquire Horizon Therapeutics for $116.50 per share in cash
- 12/12/22
- Amgen to acquire Horizon Therapeutics for $116.50 per share in cash
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 12/07/22
- Cytokinetics initiates Phase 1 clinical study of CK-3828136
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 11/15/22
- Accenture to acquire Albert Inc., terms undisclosed
- 11/03/22
- Accenture names Andrew Levy chief corporate, government affairs officer
- 12/11/22
- Adicet Bio reports data from ongoing ADI-001 Phase 1 trial
- 11/29/22
- Adicet Bio appoints Nancy Boman, M.D Chief Regulatory Officer
- 10/17/22
- RA Capital Management reports 5.5% passive stake in Adicet Bio
- $275.13 /
-3.455 (-1.24%) - 12/12/22 Stifel
- Horizon Therapeutics downgraded to Hold from Buy at Stifel
- 12/07/22 Piper Sandler
- Horizon Therapeutics price target raised to $110 from $90 at Piper Sandler
- 12/06/22 Oppenheimer
- Amgen price target raised to $310 from $300 at Oppenheimer
- 12/05/22 Piper Sandler
- Amgen price target raised to $297 from $278 at Piper Sandler
HZNP Horizon Therapeutics - $112.03 /
+14.68 (+15.08%) - 12/01/22 Jefferies
- Horizon Therapeutics price target raised to $125 from $101 at Jefferies
- 11/30/22 TD Cowen
- Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
- $78.70 /
+16.62 (+26.77%) - 12/12/22 William Blair
- Coupa Software downgraded to Market Perform from Outperform at William Blair
- 11/25/22 Raymond James
- Coupa Software takeout would be 'reasonable' at $68-$80, say Raymond James
- 11/25/22 Truist
- Truist sees 'scarcity value' in Coupa platform, keeps $75 target
- 11/25/22 BofA
- Coupa has strategic value, could also represent attractive PE target, says BofA
- 10/25/22 Wells Fargo
- Weber upgraded to Equal Weight from Underweight at Wells Fargo
- 08/17/22 Citi
- Weber downgraded to Sell from Neutral at Citi
- 08/16/22 BMO Capital
- Weber price target lowered to $6 from $7 at BMO Capital
- 08/02/22 Citi
- Weber transferred with Neutral rating at Citi
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
- 11/29/22 Evercore ISI
- Rivian Automotive initiated with an In Line at Evercore ISI
- 11/10/22 RBC Capital
- Rivian Automotive price target lowered to $50 from $61 at RBC Capital
- 11/10/22 Deutsche Bank
- Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
- 11/18/22 Lake Street
- Inotiv downgraded to Hold from Buy at Lake Street
- 10/04/22 Jefferies
- Inotiv initiated with a Buy at Jefferies
- 08/11/22 Lake Street
- Inotiv price target raised to $60 from $50 at Lake Street
- 06/14/22 Lake Street
- Inotiv price target lowered to $50 from $75 at Lake Street
- 12/12/22 KeyBanc
- Coinbase initiated with a Sector Weight at KeyBanc
- 12/12/22 Mizuho
- Fiserv price target lowered to $135 from $145 at Mizuho
- 12/09/22 Mizuho
- Coinbase downgraded to Underperform from Neutral at Mizuho
- 12/05/22 Atlantic Equities
- Coinbase price target lowered to $46 from $67 at Atlantic Equities
- 11/25/22 William Blair
- Report about Galaxy S23 'significant positive' for Iridium, says William Blair
- 08/22/22 Loop Capital
- Enovix price target raised to $100 from $50 at Loop Capital
- 08/11/22 Loop Capital
- Loop Capital has 'stronger conviction' in Enovix after 'customer milestones'
- 06/22/22 Loop Capital
- Samsung initiated with a Buy at Loop Capital
- 12/09/22 BofA
- BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential
- 12/09/22 BofA
- Credit Suisse upgraded to Buy from Neutral at BofA
- 12/01/22 JPMorgan
- Credit Suisse price target lowered to CHF 3.80 from CHF 5.50 at JPMorgan
- 11/07/22 AlphaValue/Baader
- Credit Suisse downgraded to Sell from Buy at AlphaValue/Baader
- 12/08/22 Citi
- DoD contracts shows competitiveness of cloud industry, says Citi
- 12/07/22 BTIG
- SentinelOne price target lowered to $20 from $25 at BTIG
- 12/01/22 BMO Capital
- Okta price target raised to $69 from $58 at BMO Capital
- 12/01/22 Wedbush
- Activision Blizzard added to Best Ideas List at Wedbush
- 12/06/22 Edward Jones
- Activision Blizzard upgraded to Buy from Hold at Edward Jones
- 11/28/22 JPMorgan
- Activision Blizzard price target lowered to $86 from $95 at JPMorgan
- 11/28/22 Wells Fargo
- Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target
- 12/02/22 UBS
- IAC initiated with a Sell at UBS
- 11/14/22 Wells Fargo
- IAC price target lowered to $85 from $120 at Wells Fargo
- 11/10/22 TD Cowen
- IAC price target lowered to $75 from $80 at Cowen
- 11/10/22 Truist
- IACprice target lowered to $120 from $155 at Truist
- 07/08/22 H.C. Wainwright
- Meridian Bioscience downgraded to Neutral from Buy at H.C. Wainwright
- 07/07/22 William Blair
- Meridian Bioscience downgraded to Market Perform from Outperform at William Blair
- 02/07/22 H.C. Wainwright
- Meridian Bioscience price target raised to $30 from $28 at H.C. Wainwright
- 12/12/22 JPMorgan
- JPMorgan upgrades 'undervalued profitable growth story' Box to buy
- 12/12/22 JPMorgan
- Box upgraded to Overweight from Neutral at JPMorgan
- 11/21/22 Credit Suisse
- Box initiated with an Outperform at Credit Suisse
- 10/03/22 Morgan Stanley
- Morgan Stanley upgrades Box on 'strong large deal momentum'
- 12/12/22 H.C. Wainwright
- Adicet Bio price target raised to $38 from $34 at H.C. Wainwright
- 09/21/22 JPMorgan
- Adicet Bio initiated with Overweight, $23 target at JPMorgan
- 09/21/22 JPMorgan
- Adicet Bio initiated with an Overweight at JPMorgan
- 03/30/22 SMBC Nikko
- Adicet Bio initiated with an Outperform at SMBC Nikko
- 11/04/22 RBC Capital
- Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
- 11/04/22 RBC Capital
- Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
- 08/05/22 Baird
- Karyopharm price target lowered to $14 from $17 at Baird
- 08/05/22 Barclays
- Karyopharm price target lowered to $8 from $14 at Barclays
- 12/12/22 Oppenheimer
- Fate Therapeutics price target lowered to $65 from $90 at Oppenheimer
- 11/16/22 Citi
- Fate Therapeutics price target lowered to $80 from $87 at Citi
- 11/04/22 Cantor Fitzgerald
- Fate Therapeutics assumed with an Overweight at Cantor Fitzgerald
- 10/10/22 Canaccord
- Fate Therapeutics initiated with a Buy at Canaccord
- 09/13/22 H.C. Wainwright
- GT Biopharma price target lowered to $5 from $25 at H.C. Wainwright
- 08/11/22 Roth MKM
- Roth cuts GT Biopharma to Neutral after filings for TriKE programs pushed back
- 08/11/22 Roth MKM
- GT Biopharma downgraded to Neutral from Buy at Roth Capital
- 01/24/22 B. Riley
- GT Biopharma price target lowered to $18 from $26 at B. Riley
- 11/21/22 TD Cowen
- Whole Earth Brands price target lowered to $11 from $14 at Cowen
- 11/10/22 Canaccord
- Whole Earth Brands price target lowered to $8 from $10 at Canaccord
- 03/15/22 Lake Street
- Whole Earth Brands price target lowered to $16 from $19 at Lake Street
- 03/15/22 Cantor Fitzgerald
- Whole Earth Brands price target lowered to $19.00 from $24.75 at Cantor Fitzgerald
- 07/11/22 Rosenblatt
- Universal Technical initiated with a Buy at Rosenblatt
- 06/28/22 Argus
- Argus upgrades Universal Technical to Buy on expansion efforts, valuation
- 06/28/22 Argus
- Universal Technical upgraded to Buy from Hold at Argus
- 05/05/22 Barrington
- Universal Technical price target raised to $14 from $10 at Barrington
- 04/27/22 Jefferies
- Dynagas LNG reinstated with a Hold at Jefferies
- 12/09/22 Credit Suisse
- Pembina Pipeline downgraded to Neutral from Outperform at Credit Suisse
- 11/07/22 National Bank
- Pembina Pipeline price target raised to C$46 from C$45 at National Bank
- 11/04/22 Raymond James
- Pembina Pipeline price target lowered to C$46 from C$49 at Raymond James
- 10/20/22 Scotiabank
- Pembina Pipeline price target lowered to C$50 from C$55 at Scotiabank
- 12/12/22 Deutsche Bank
- Micron downgraded to Hold from Buy at Deutsche Bank
- 12/07/22 Wells Fargo
- Micron price target lowered to $70 from $75 at Wells Fargo
- 12/05/22 Lynx
- Micron price target raised to $60 from $56 at Lynx
- 11/30/22 Stifel
- Micron management's tone 'incrementally downbeat,' says Stifel
- $252.26 /
-22.08 (-8.05%) - 12/12/22 TD Cowen
- RH price target lowered to $320 from $350 at Cowen
- 12/12/22 Loop Capital
- RH price target lowered to $370 from $420 at Loop Capital
- 12/12/22 Barclays
- RH price target raised to $254 from $243 at Barclays
- 12/12/22 Goldman Sachs
- RH downgraded to Sell from Neutral at Goldman Sachs
- 12/12/22 Stifel
- Under Armour upgraded to Buy from Hold at Stifel
- 11/07/22 JPMorgan
- Under Armour price target raised to $11 from $10 at JPMorgan
- 11/01/22 BofA
- Under Armour reinstated with a Neutral at BofA
- 10/31/22 JPMorgan
- Under Armour price target lowered to $10 from $12 at JPMorgan
- 12/12/22 Wells Fargo
- Wells Fargo downgrades Qualcomm to Underweight with $105 price target
- 12/12/22 Wells Fargo
- Qualcomm downgraded to Underweight from Equal Weight at Wells Fargo
- 11/15/22 Credit Suisse
- Qualcomm initiated with an Outperform at Credit Suisse
- 11/03/22 KeyBanc
- Qualcomm price target lowered to $150 from $170 at KeyBanc
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 09/27/22 Alliance Global Partners
- Perficient upgraded to Buy from Neutral at Alliance Global Partners
- 12/12/22 Goldman Sachs
- Gap upgraded to Buy from Neutral at Goldman Sachs
- 11/21/22 Deutsche Bank
- Gap price target raised to $11 from $8 at Deutsche Bank
- 11/21/22 Barclays
- Gap price target raised to $14 from $9 at Barclays
- 11/18/22 Jefferies
- Gap price target raised to $13 from $11 at Jefferies
- 12/12/22 Goldman Sachs
- Tapestry upgraded to Buy from Neutral at Goldman Sachs
- 11/29/22 JPMorgan
- Tapestry price target raised to $47 from $46 at JPMorgan
- 11/14/22 Citi
- Tapestry price target lowered to $40 from $42 at Citi
- 11/11/22 Morgan Stanley
- Tapestry price target lowered to $35 from $39 at Morgan Stanley
- 12/12/22 Goldman Sachs
- Levi Strauss downgraded to Neutral from Buy at Goldman Sachs
- 11/29/22 JPMorgan
- Levi Strauss price target lowered to $19 from $20 at JPMorgan
- 10/10/22 Citi
- Levi Strauss price target lowered to $19 from $27 at Citi
- 10/07/22 Guggenheim
- Levi Strauss price target lowered to $27 from $33 at Guggenheim
- 08/15/22
- Weber reports Q3 EPS (41c)
- 07/25/22
- Weber withdraws FY22 guidance, suspends dividend
- 07/25/22
- Weber sees Q3 revenue $525M-$530M, consensus $532.74M
- 11/22/22
- Meridian Bioscience reports Q4 adjusted EPS 20c vs. 23c a year ago
- 08/05/22
- Meridian Bioscience reports Q3 adjusted EPS 16c, consensus 16c
- 07/07/22
- Meridian Bioscience sees Q3 revenue $66M-$69M
- 12/12/22
- Virco reports Q3 EPS 48c vs. 8c last year
- 12/12/22
- Universal Technical reports Q4 EPS 3c vs 20c last year
- 11/21/22
- Universal Technical sees FY22 revenue $418.8M, consensus $418.98M
- 08/03/22
- Universal Technical narrows FY22 revenue view to $410M-$420M from $405.0M-$420M
- 08/03/22
- Universal Technical reports Q3 EPS (1c) vs. 3c a year ago
- 11/03/22
- Under Armour cuts FY23 EPS view to 56c-60c from 61c-67c, consensus 43c
- 11/03/22
- Under Armour reports Q2 adjusted EPS 20c, consensus 16c
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/10/22
- Tapestry sees FY23 EPS $3.60-$3.70, consensus $3.82
- 11/10/22
- Tapestry reports Q1 EPS 79c, consensus 75c
- 11/09/22
- Notable companies reporting before tomorrow's open
- 10/26/22
- Samsung reports Q3 net profit KRW 9.39T vs. KRW 12.29T last year
- 10/06/22
- Samsung sees Q3 operating profit KRW10.8T vs. KRW12.1T consensus
- 07/28/22
- Samsung reports Q2 EPS KRW 1,613 vs. KRW 1,391 last year
- 07/06/22
- Samsung sees Q2 operating profit KRW14.0T vs. KRW14.6T consensus
- 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
- 11/09/22
- Notable companies reporting after market close
- 10/27/22
- Amazon reports Q3 EPS 28c with Rivian gain, consensus 21c
- 08/11/22
- Rivian Automotive reports Q2 EPS ($1.89), consensus ($1.67)
- $252.26 /
-22.08 (-8.05%) - 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 11/02/22
- Qualcomm sees Q1 adjusted EPS adjusted EPS $2.25-$2.45, consensus $3.42
- 11/02/22
- Qualcomm reports Q4 adjusted EPS $3.13, consensus $3.13
- 11/02/22
- Notable companies reporting after market close
- 07/27/22
- Qualcomm sees Q4 adjusted EPS $3.00-$3.30, consensus $3.23
- 12/12/22
- Pembina Pipeline sees FY23 adjusted EBITDA C$3.5B-C$3.8B
- 11/03/22
- Pembina Pipeline reports Q3 EPS C$3.23 vs. C$1.01 a year ago
- 08/04/22
- Pembina Pipeline raises FY22 adjusted EBITDA view to C$3.575B-C$3.675B
- 08/04/22
- Pembina Pipeline reports Q2 EPS C$0.69 vs. C$0.39 a year ago
- 12/12/22
- Inotiv sees 2022 revenue $547.7M, consensus $550.98M
- 09/29/22
- Micron sees Q2 revenue range similar to Q1
- 09/29/22
- Micron sees Q1 adjusted EPS 4c, plus or minus 10c, consensus 64
- 09/29/22
- Micron reports Q4 adjusted EPS $1.45, consensus $1.30
- 09/29/22
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 10/25/22
- Notable companies reporting after market close
- 07/26/22
- Microsoft sees FY23 revenue growth in double digits, consensus $225.98B
- 10/06/22
- Levi Strauss cuts FY22 EPS view to $1.44-$1.49 from $1.50-$1.56
- 10/06/22
- Levi Strauss reports Q3 EPS 40c, consensus 37c
- 07/07/22
- Levi Strauss backs FY22 adjusted EPS view $1.50-$1.56, consensus $1.55
- 07/07/22
- Levi Strauss reports Q2 adjusted EPS 29c, consensus 23c
- 11/03/22
- Karyopharm sees FY22 revenue $155M-$165M, consensus $157.23M
- 11/03/22
- Karyopharm reports Q3 EPS (45) with items, consensus (57c)
- 08/04/22
- Karyopharm sees 2022 revenue $155M-$165M, consensus $160.03M
- 08/04/22
- Karyopharm reports Q2 EPS (62c), consensus (63c)
- 11/08/22
- IAC reports Q3 EPS (74c), consensus (52c)
- 08/09/22
- IAC reports Q2 EPS ($10.02), consensus (37c)
HZNP Horizon Therapeutics - $112.03 /
+14.68 (+15.08%) - 11/02/22
- Horizon Therapeutics sees FY22 revenue s $3.59B-$3.61B, consensus $3.56B
- 11/02/22
- Horizon Therapeutics reports Q3 EPS $1.25, consensus $1.01
- 08/03/22
- Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B
- 08/03/22
- Horizon Therapeutics reports Q2 adjusted EPS $1.07, consensus $1.35
- 11/17/22
- Gap reports Q3 Gap brand revenue $1.04B, flat y/y
- 11/17/22
- Gap sees Q4 revenue down mid-single digits, consensus $4.5B
- 11/17/22
- Gap reports Q3 adjusted EPS 71c, consensus 0c
- 11/17/22
- Notable companies reporting after market close
- 12/12/22
- Whole Earth Brands reaffirms 2022 guidance
- 11/09/22
- Whole Earth Brands sees 2022 revenue $535M-$545M, consensus $535.57M
- 11/09/22
- Whole Earth Brands reports Q3 EPS (6c), consensus 8c
- 08/09/22
- Whole Earth Brands reiterates FY22 revenue view $530M-$545M, consensus $536.83M
- 11/03/22
- Fate Therapeutics reports Q3 EPS (86c), consensus (89c)
- 08/03/22
- Fate Therapeutics reports Q2 EPS (79c), consensus (83c)
- 12/12/22
- Dynagas LNG reports Q3 adjusted EPS 4c vs. 24c last year
- 09/22/22
- Dynagas LNG reports Q2 EPS 17c vs. 20c in last year's quarter
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 07/27/22
- Credit Suisse reports Q2 net revenue CHF3.6B vs. CHF5.1B last year
- $78.70 /
+16.62 (+26.77%) - 12/12/22
- Coupa Software reports Q3 non-GAAP EPS 15c, consensus 10c
- 09/06/22
- Coupa Software sees FY23 non-GAAP EPS 37c-44c, consensus 26c
- 09/06/22
- Coupa Software sees Q3 non-GAAP EPS 8c-10c, consensus 6c
- 09/06/22
- Coupa Software reports Q2 non-GAAP EPS 20c, consensus 9c
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 11/03/22
- Coinbase reports Q3 EPS ($2.43), consensus ($2.40)
- 08/09/22
- Coinbase reports Q2 EPS ($4.98), consensus ($2.65)
- 11/30/22
- Box raises FY23 EPS view to $1.16-$1.17 from $1.13-$1.16, consensus $1.14
- 11/30/22
- Box sees Q4 adjusted EPS 34c-35c, consensus 33c
- 11/30/22
- Box reports Q3 adjusted EPS 31c, consensus 30c
- 11/30/22
- Notable companies reporting after market close
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- 11/07/22
- Notable companies reporting after market close
- 08/01/22
- Activision Blizzard reports Q2 adjusted EPS 48c, consensus 48c
- 08/01/22
- Notable companies reporting after market close
- $275.13 /
-3.455 (-1.24%) - 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 09/22/22
- Accenture sees FY23 EPS $11.09-$11.41, consensus $12.00
- 09/22/22
- Accenture reports Q4 EPS $2.60, consensus $2.58
- 06/23/22
- Accenture sees Q4 revenue $15B-$15.5B, consensus $14.83B
- 11/08/22
- Adicet Bio reports Q3 EPS (53c), consensus (53c)
- 08/10/22
- Adicet Bio reports Q2 EPS (56c), consensus (45c)
|
|
Hot Stocks
|
Universal Technical is… Universal Technical is down -16.3%, or -$1.17 to $5.99. ShowHide Related Items >><< - 12/12/22
- Universal Technical falls -10.6%
- 12/12/22
- Universal Technical trading resumes
- 12/12/22
- Universal Technical trading halted, volatility trading pause
- 06/27/22
- Universal Technical rejoins Russell 3000 Index
- 07/11/22 Rosenblatt
- Universal Technical initiated with a Buy at Rosenblatt
- 06/28/22 Argus
- Argus upgrades Universal Technical to Buy on expansion efforts, valuation
- 06/28/22 Argus
- Universal Technical upgraded to Buy from Hold at Argus
- 05/05/22 Barrington
- Universal Technical price target raised to $14 from $10 at Barrington
- 12/12/22
- Universal Technical reports Q4 EPS 3c vs 20c last year
- 11/21/22
- Universal Technical sees FY22 revenue $418.8M, consensus $418.98M
- 08/03/22
- Universal Technical narrows FY22 revenue view to $410M-$420M from $405.0M-$420M
- 08/03/22
- Universal Technical reports Q3 EPS (1c) vs. 3c a year ago
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
|
|
Hot Stocks
|
Universal Technical is… Universal Technical is down -10.6%, or -76c to $6.39. ShowHide Related Items >><< - 12/12/22
- Universal Technical trading resumes
- 12/12/22
- Universal Technical trading halted, volatility trading pause
- 06/27/22
- Universal Technical rejoins Russell 3000 Index
- 07/11/22 Rosenblatt
- Universal Technical initiated with a Buy at Rosenblatt
- 06/28/22 Argus
- Argus upgrades Universal Technical to Buy on expansion efforts, valuation
- 06/28/22 Argus
- Universal Technical upgraded to Buy from Hold at Argus
- 05/05/22 Barrington
- Universal Technical price target raised to $14 from $10 at Barrington
- 12/12/22
- Universal Technical reports Q4 EPS 3c vs 20c last year
- 11/21/22
- Universal Technical sees FY22 revenue $418.8M, consensus $418.98M
- 08/03/22
- Universal Technical narrows FY22 revenue view to $410M-$420M from $405.0M-$420M
- 08/03/22
- Universal Technical reports Q3 EPS (1c) vs. 3c a year ago
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
|
